Outcome Analysis in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy with Lu-177-DOTATATE.
JOURNAL OF GASTROINTESTINAL ONCOLOGY（2023）
Key words
Peptide receptor radionuclide therapy (PRRT),neuroendocrine tumors (NET),Lu-177-DOTATATE,selective internal radiation therapy (SIRT),somatostatin analogue therapy (SSA),health-related quality of life (HRQoL),mortality
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined